PRICE T ROWE ASSOCIATES INC /MD/ - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 67 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$128,000
-28.1%
26,000
-22.8%
0.00%
Q2 2021$178,000
-41.8%
33,700
-47.1%
0.00%
Q1 2021$306,000
+10.9%
63,7000.0%0.00%
Q4 2020$276,000
+5.3%
63,7000.0%0.00%
Q3 2020$262,000
+21.3%
63,700
-24.4%
0.00%
Q2 2020$216,000
-12.9%
84,300
-1.7%
0.00%
Q1 2020$248,000
-5.0%
85,739
+24.4%
0.00%
Q4 2019$261,000
-13.3%
68,939
+17.0%
0.00%
Q3 2019$301,000
-17.5%
58,928
+0.2%
0.00%
Q2 2019$365,000
+305.6%
58,797
+366.8%
0.00%
Q1 2019$90,000
-15.9%
12,597
+0.8%
0.00%
Q4 2018$107,000
-68.0%
12,497
-25.0%
0.00%
Q3 2018$334,000
-21.8%
16,661
+0.8%
0.00%
Q2 2018$427,00016,5320.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
C Partners Holding GmbH 1,662,128$29,037,0009.28%
GREAT POINT PARTNERS LLC 608,650$10,645,0004.68%
Opaleye Management Inc. 255,000$4,460,0002.07%
EMERALD MUTUAL FUND ADVISERS TRUST 326,530$5,721,0000.47%
Granite Point Capital Management, L.P. 61,813$1,076,0000.39%
WALL STREET ASSOCIATES 225,000$3,935,0000.37%
EMERALD ADVISERS, LLC 322,631$5,652,0000.28%
Spark Investment Management LLC 75,500$1,317,0000.18%
TFS CAPITAL LLC 98,443$1,722,0000.17%
PRIVATE ASSET MANAGEMENT INC 47,690$834,0000.14%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders